Login
$ECG
$101.76 +$3.58 (3.65%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Assets
Current assets:
Cash and cash equivalents
Cash, cash equivalents and restricted cash
Receivables, net of allowance for credit losses of $5,365 and $5,282, respectively
Nonrelated party
Related party
Total receivables, net of allowance for credit losses of $5,365 and $5,282, respectively
Contract assets
Inventories, net
Prepayments and other current assets
Prepaid expenses
Other current assets
Total current assets
Noncurrent assets:
Investments
Property, plant and equipment, net of accumulated depreciation of $187,037 and $174,914, respectively
Operating lease right-of-use assets
Related party
Total operating lease right-of-use assets
Noncurrent retention receivable
Goodwill
Other intangible assets, net of accumulated amortization of $3,247 as of June 30, 2026
Other noncurrent assets
Total noncurrent assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Current portion of long-term debt
Accounts payable
Contract liabilities, net
Taxes payable
Accrued compensation
Accrued payroll-related liabilities
Current portion of operating lease liabilities
Related party
Total current portion of operating lease liabilities
Other accrued liabilities
Nonrelated party
Related party
Total other accrued liabilities
Total current liabilities
Noncurrent liabilities:
Long-term debt, net of unamortized issuance costs
Nonrelated party
Related party
Total long-term debt, net of unamortized issuance costs
Deferred income taxes
Operating lease liabilities
Related party
Total operating lease liabilities
Other noncurrent liabilities
Total noncurrent liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, 10,000,000 shares authorized, $0.01 par value, none issued and outstanding
Common stock, 300,000,000 shares authorized, $0.01 par value, 51,063,836 and 51,006,719 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Retained earnings
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support